Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yanyou Li
Diplatin, a Novel and Low-Toxicity Anti-Lung Cancer Platinum Complex, Activation of Cell Death in Tumors via a ROS/JNK/p53-Dependent Pathway, and a Low Rate of Acquired Treatment Resistance
Frontiers in Pharmacology
Pharmacology
Related publications
A Novel Chromone Derivative With Anti-Inflammatory Property via Inhibition of ROS-Dependent Activation of TRAF6-ASK1-p38 Pathway
PLoS ONE
Multidisciplinary
Anti-Cancer Effects of JKA97 Are Associated With Its Induction of Cell Apoptosis via a Bax-Dependent and P53-Independent Pathway.
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Pristimerin Induces Apoptosis and Autophagy via Activation of ROS/ASK1/JNK Pathway in Human Breast Cancer in Vitro and in Vivo
Cell Death Discovery
Cancer Research
Molecular Neuroscience
Immunology
Cell Biology
Cellular
ROS/Autophagy/Nrf2 Pathway Mediated Low-Dose Radiation Induced Radio-Resistance in Human Lung Adenocarcinoma A549 Cell
International Journal of Biological Sciences
Applied Microbiology
Evolution
Ecology
Developmental Biology
Cell Biology
Molecular Biology
Systematics
Behavior
Biotechnology
Candidate Pathway-Based Genetic Association Study of Platinum and Platinum–taxane Related Toxicity in a Cohort of Primary Lung Cancer Patients
Journal of the Neurological Sciences
Neurology
Sophoridine Induces Apoptosis and S Phase Arrest via ROS-dependent JNK and ERK Activation in Human Pancreatic Cancer Cells
Journal of Experimental and Clinical Cancer Research
Cancer Research
Oncology
Oleanolic Acid Induces P53-Dependent Apoptosis via the ERK/JNK/AKT Pathway in Cancer Cell Lines in Prostatic Cancer Xenografts in Mice
Oncotarget
Oncology
FLLL12 Induces Apoptosis in Lung Cancer Cells Through a P53/P73-Independent but Death Receptor 5-Dependent Pathway
Cancer Letters
Cancer Research
Oncology
Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-mutant Non-Small Cell Lung Cancer Cells
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
